Literature DB >> 659633

Kinetics of human connecting peptide in normal and diabetic subjects.

O K Faber, C Hagen, C Binder, J Markussen, V K Naithani, P M Blix, H Kuzuya, D L Horwitz, A H Rubenstein, N Rossing.   

Abstract

The metabolic clearance rate (MCR) of synthetic human connecting peptide (C-peptide) was measured with a single-dose injection technique in six normal and seven diabetic subjects and with a constant infusion technique in one normal subject. The MCR of C-peptide did not differ in normal subjects (4.4 ml/min per kg; range, 3.7-4.9) and in diabetic subjects (4.7 ml/min per kg; range, 3.7-5.8). Employment of both techniques in one subject gave similar MCR. The average half-life of C-peptide in plasma calculated from the last 1-h period of the single-dose injection studies was longer in the insulin-dependent diabetics (42.5 min; range, 39.4-48.5) than in the normal subjects (33.5 min; range, 24.9-45.3). These results indicate that the beta-cell secretory capacity of normal and insulin-dependent diabetic subjects can be compared by measuring the C-peptide concentration in peripheral venous plasma. The difference in the half-life of C-peptide in plasma between diabetics and normals suggests an altered kinetics of the disappearance of the peptide, while the overall metabolism, as expressed by the MCR, is similar.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659633      PMCID: PMC371754          DOI: 10.1172/JCI109106

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma.

Authors:  D F Steiner; P E Oyer
Journal:  Proc Natl Acad Sci U S A       Date:  1967-02       Impact factor: 11.205

2.  Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects.

Authors:  F P Alford; S R Bloom; J D Nabarro
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

3.  Heterogeneity of circulating C-peptide.

Authors:  H Kuzuya; P M Blix; D L Horwitz; A H Rubenstein; D F Steiner; C Binder; O K Faber
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

4.  Turnover in humans of iodine- and cobalamin-labeled transcobalamin I and of iodine-labeled albumin.

Authors:  E Nexö; P Gimsing
Journal:  Scand J Clin Lab Invest       Date:  1975-09       Impact factor: 1.713

5.  The analysis of decay curves.

Authors:  H H Lafferty; A E Giddings; D Mangnall
Journal:  Clin Sci Mol Med       Date:  1977-01

6.  C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.

Authors:  O K Faber; C Binder
Journal:  Diabetes       Date:  1977-07       Impact factor: 9.461

7.  Disappearance rate of endogenous human C-peptide from blood.

Authors:  T Kuzuya; A Matsuda
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

8.  Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin.

Authors:  O K Faber; J Markussen; V K Naithani; C Binder
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-06

9.  C-peptide and insulin during blockade of the hyperglycaemic response to surgery by epidural analgesia.

Authors:  M R Brandt; H Kehlet; O Faber
Journal:  Clin Endocrinol (Oxf)       Date:  1977-02       Impact factor: 3.478

10.  Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

Authors:  D G Johnson; K G Alberti; O K Faber; C Binder
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

View more
  64 in total

1.  Automated chemiluminescent assay for C-peptide.

Authors:  R W Hardy; M Cohn; R J Konrad
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells.

Authors:  N M Al-Rasheed; F Meakin; E L Royal; A J Lewington; J Brown; G B Willars; N J Brunskill
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

Review 3.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

4.  The effect of exercise on the absorption of inhaled human insulin in healthy volunteers.

Authors:  Astrid H Petersen; Gerd Köhler; Stefan Korsatko; Andrea Wutte; Manfred Wonisch; Agnes Mautner; Birgitte B Rønn; Per Clauson; Torben Laursen; Per Wollmer; Thomas R Pieber
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

5.  Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance.

Authors:  Ron T Varghese; Chiara Dalla Man; Marcello C Laurenti; Francesca Piccinini; Anu Sharma; Meera Shah; Kent R Bailey; Robert A Rizza; Claudio Cobelli; Adrian Vella
Journal:  Diabetes Obes Metab       Date:  2017-09-27       Impact factor: 6.577

6.  C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

Authors:  K S Polonsky; W Pugh; J B Jaspan; D M Cohen; T Karrison; H S Tager; A H Rubenstein
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

7.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

Authors:  C Bogardus; S Lillioja; B V Howard; G Reaven; D Mott
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

8.  Obesity-related markers and breast cancer in CPS-II Nutrition Cohort.

Authors:  Mia M Gaudet; Alpa V Patel; Lauren R Teras; Juzhong Sun; Peter T Campbell; Victoria L Stevens; Eric J Jacobs; Susan M Gapstur
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

9.  Paradoxical inhibition of insulin secretion by glucose in non-insulin-dependent diabetic patients.

Authors:  M Linstow; K J Mikines; F Dela; H Galbo
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

10.  Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

Authors:  G B Bolli; E Tsalikian; M W Haymond; P E Cryer; J E Gerich
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.